Descarga la app Emergencing

Admission Acid-Base Status and Mortality in Cardiac Intensive Care Unit Patients

Revista

Journal of Intensive Care Medicine

Fecha de publicación

28 de noviembre de 2025

J Intensive Care Med. 2025 Nov 28:8850666251399182. Revista: 10.1177/08850666251399182. Online ahead of print.

BackgroundThere is limited evidence on the epidemiology and prognostic significance of acid-base disorders in the cardiovascular intensive care unit (CICU). This study examines the association of acid-base status at admission with in-hospital mortality among CICU patients.MethodsWe conducted a retrospective analysis of adults admitted to the Mayo Clinic CICU from 2007-2018 with available blood gas data, utilizing values obtained closest to CICU admission. Arterial pH, serum bicarbonate, base excess, and partial pressure of carbon dioxide (PaCO2) were examined as predictors of in-hospital mortality. Multivariable logistic regression was used to assess associations, with adjustment for demographics, comorbidities, illness severity, and interventions.ResultsAmong 3229 patients included for analysis, acidemia (pH < 7.35) emerged as the strongest predictor of in-hospital mortality (adjusted odds ratio [aOR] 1.60, 95% confidence interval [CI] 1.29-1.98, P < .003). Metabolic acidosis (HCO3 < 20 mEq/L, aOR 1.55, 95% CI 1.24-1.95, P 45 mm Hg, aOR 1.44, 95% CI 1.14-1.81, P = .002) were associated with higher in-hospital mortality, whereas metabolic and respiratory alkalosis were not. After adjustment, lower pH and more negative base excess were associated with higher in-hospital mortality (both P < .001), whereas HCO3 and PaCO2 were not (P = .053 and P = .051, respectively). Patients with combined metabolic and respiratory acidosis had the highest in-hospital mortality (56.3%).ConclusionsShort-term survival in CICU patients decreases progressively with worse acidemia, especially in the context of combined metabolic and respiratory acidosis. Incorporating metabolic acid-base disorders as key therapeutic targets in randomized cardiogenic shock trials may improve outcomes in this complex population by addressing hemometabolic shock.

PubMed:41313337 | Revista:10.1177/08850666251399182

Descarga la app Emergencing!

Accede a los abstracts en español de las revistas científicas más importantes en medicina de urgencias, emergencias y paciente crítico.

Descargo de responsabilidad
El idioma original es este artículo es el inglés. Mediante el sistema de traducción automático de la IA de emergencing, el contenido se ha traducido al español. Esta es una traducción no supervisada por lo que puede que alguna parte del contenido no refleje con exactitud la publicación original del autor/autores.